mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
1e-09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-09 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-09 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-09 |